AVGR - Avangardco Investments Public Ltd Stock Price, Fair Value and News

$0.470.00 (0.00%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AVGR Price Action

Last 30 days

-16.1%


Last 90 days

-42.0%


Trailing 12 Months

-85.8%

AVGR Stock Price

AVGR RSI Chart

JunJulAugSepOctNovDec2025FebMar010203040506070

AVGR Valuation

Market Cap

1.5M

Price/Earnings (Trailing)

-0.08

Price/Sales (Trailing)

0.21

EV/EBITDA

0.07

Price/Free Cashflow

-0.13

AVGR Price/Sales (Trailing)

202220232024202502468

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AVGR Fundamentals

AVGR Revenue

2014201620182020202220248M10M12M14M16M18M20M

AVGR Earnings

201420162018202020222024-60M-50M-40M-30M-20M

AVGR Profitability

Free Cashflow Yield

-771.96%

AVGR Investor Care

Revenue Breakdown

As of: Sep 30, 2024
201620182020202220241M2M3M4M5M
Total
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2014201620182020202220248M10M12M14M16M18M20M
Net sales
YearQ1Q2Q3Q4
20247.6M7.4M7.3M0
20238.3M8.2M7.7M7.7M
20229.5M8.8M8.7M8.3M
20219.1M10.4M10.5M10.1M
20209.6M8.7M8.6M8.8M
20197.9M8.2M8.6M9.1M
20188.3M7.9M7.8M7.9M
201718.2M15.9M12.7M9.9M
201613.2M14.8M17.4M19.2M
201511.2M10.8M10.9M10.7M
201412.5M12.1M11.7M11.2M
201300013.0M
Get all data in R, Python etc through our Historical Stock Data APIs
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

Avangardco Investments Public Ltd Frequently Asked Questions


What is the ticker symbol for Avangardco Investments Public Ltd? What does AVGR stand for in stocks?

AVGR is the stock ticker symbol of Avangardco Investments Public Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Avangardco Investments Public Ltd (AVGR)?

As of Thu Mar 13 2025, market cap of Avangardco Investments Public Ltd is 1.5 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVGR stock?

You can check AVGR's fair value in chart for subscribers.

Is Avangardco Investments Public Ltd a good stock to buy?

The fair value guage provides a quick view whether AVGR is over valued or under valued. Whether Avangardco Investments Public Ltd is cheap or expensive depends on the assumptions which impact Avangardco Investments Public Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVGR.

What is Avangardco Investments Public Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Mar 13 2025, AVGR's PE ratio (Price to Earnings) is -0.08 and Price to Sales (PS) ratio is 0.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVGR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Avangardco Investments Public Ltd's stock?

In the past 10 years, Avangardco Investments Public Ltd has provided -0.771 (multiply by 100 for percentage) rate of return.